Company Directory - Formation Bio
Company Details - Formation Bio
Formation Bio
WebsiteFormation Bio is a biotechnology company specializing in drug discovery and development using AI technology.
CCI Score
CCI Score: Formation Bio
63.97
-0.04%
Latest Event
Formation Bio Joins AI-Driven Drug Discovery Partnership
Formation Bio, in collaboration with Sanofi and OpenAI, is participating in a pioneering project to accelerate drug development using artificial intelligence. The initiative aims to significantly reduce drug development timelines, potentially benefiting public health and marginalized communities by improving timely access to innovative treatments.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
LEADER
Formation Bio is currently rated as a Leader.
Latest Events
- JUN032024
Formation Bio, in collaboration with Sanofi and OpenAI, is participating in a pioneering project to accelerate drug development using artificial intelligence. The initiative aims to significantly reduce drug development timelines, potentially benefiting public health and marginalized communities by improving timely access to innovative treatments.
+60
Technology and Services Impact
March 28
The collaboration leverages cutting-edge AI technology to streamline drug development, which could significantly reduce the traditional long timelines in pharmaceutical research. This innovation has the potential to benefit public health and marginalized communities by expediting access to essential medications, thereby aligning with progressive, anti-authoritarian values.
Sanofi’s bold ambitions in AI:Pioneering collaboration with OpenAI and Formation BIO
- MAY222024
Formation Bio joined forces with Sanofi and OpenAI to leverage AI technology in speeding up drug discovery, potentially reducing development times and costs for life-saving treatments.
+80
Technology and Services Impact
March 28
The collaboration leverages AI-driven innovation to streamline drug discovery, a positive development that enhances public health outcomes. Formation Bio's role in this partnership demonstrates a commitment to using technology for societal benefit rather than contributing to oppressive practices.
AI to the Rescue: Sanofi, OpenAI, and Formation Bio Team Up to Speed Up Drug Discovery!
- MAY212024
Formation Bio has joined Sanofi and OpenAI in a new partnership aimed at developing AI-powered software for drug research and development, potentially accelerating innovation in healthcare and improving public access to advanced treatments.
+70
Technology and Services Impact
March 28
The partnership leverages advanced AI technology in drug discovery, representing a progressive and socially beneficial use of technology. By accelerating drug research and development, the collaboration has the potential to democratize access to healthcare and benefit marginalized communities, aligning with anti-fascist values of promoting public welfare and accountability in technological innovation.
Sanofi, OpenAI, Formation Bio announce AI drug development partnership
Alternatives
Corporation
0.00
Corporation
0.00
Dallas, United States
44.45
South San Francisco, United States
2.18
Corporation
28.68
Corporation
11.46
Corporation
0.00
Corporation
0.00
Corporation
0.00
Corporation
-5.66
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)